Long-term Follow-up (LTFU)
Research type
Research Study
Full title
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells.
IRAS ID
1013360
Contact name
Jenny Kim
Contact email
Sponsor organisation
Kite Pharma, Inc.
Eudract number
2020-005843-21
ISRCTN Number
N/A
Clinicaltrials.gov Identifier
Research summary
This is a long term follow up study for patients that have received an experimental gene-modified cell therapy treatment in a previous study sponsored by Kite Pharma, Inc. The purpose of this study is to monitor participants for any delayed side effects that may be related to the gene-modified cell therapy treatment that they have received.
These participants will be monitored for up to 15 years and will require participants to visit the hospital every 3-6 months for the first 2 years followed by yearly visits until the study ends or the participant completes all of the study visits required. During these visits participants will complete questionnaires and blood tests to monitor their overall health and wellbeing.
REC name
Wales REC 2
REC reference
26/WA/0076
Date of REC Opinion
14 May 2026
REC opinion
Further Information Favourable Opinion